Exogenous human urinary kallidinogenase increases cerebral blood flow in patients with acute ischemic stroke

References

1. ↵
   1. Duong TQ

   (2011) MRI in experimental stroke. Methods Mol Biol 711, 473–485.
2. ↵
   1. Pan F,
   2. Hernandez L,
   3. Ward A

   (2012) Cost-effectiveness of stroke treatments and secondary preventions. Expert Opin Pharmacother 13, 1751–1760.
3. ↵
   1. Ishiguro M,
   2. Kawasaki K,
   3. Suzuki Y,
   4. Ishizuka F,
   5. Mishiro K,
   6. Egashira Y,
   7. et al.

   (2012) A Rho kinase (ROCK) inhibitor, fasudil, prevents matrix metalloproteinase-9-related hemorrhagic transformation in mice treated with tissue plasminogen activator. Neuroscience 220, 302–312.
4. ↵
   1. Bennink E,
   2. Horsch AD,
   3. Dankbaar JW,
   4. Velthuis BK,
   5. Viergever MA,
   6. de Jong HW

   (2015) CT perfusion analysis by nonlinear regression for predicting hemorrhagic transformation in ischemic stroke. Med Phys 42, 4610–4618.
5. ↵
   1. Han L,
   2. Li J,
   3. Chen Y,
   4. Zhang M,
   5. Qian L,
   6. Chen Y,
   7. et al.

   (2015) Human Urinary Kallidinogenase Promotes Angiogenesis and Cerebral Perfusion in Experimental Stroke. PLoS One 10, e0134543.
6. ↵
   1. Chen ZB,
   2. Huang DQ,
   3. Niu FN,
   4. Zhang X,
   5. Li EG,
   6. Xu Y

   (2010) Human urinary kallidinogenase suppresses cerebral inflammation in experimental stroke and downregluates nuclear fator-kappaB. J Cere Blood Flow Metab 30, 1356–1365.
7. ↵
   1. Li J,
   2. Chen Y,
   3. Zhang X,
   4. Zhang B,
   5. Zhang M,
   6. Xu Y

   (2015) Human Urinary Kallidinogenase Improves Outcome of Stroke Patients by Shortening Mean Transit Time of Perfusion Magnetic Resonance Imaging. J Stroke Cerebrovasc Dis 24, 1730–1737.
8. 1. Zhang C,
   2. Tao W,
   3. Liu M,
   4. Wang D

   (2012) Efficacy and safety of human urinary kallidinogenase injection for acute ischemic stroke: a systematic review. J Evid Based Med 5, 31–39.
9. ↵
   1. Wang YX,
   2. Chen Y,
   3. Zhang CH,
   4. Li CH,
   5. Dong Z,
   6. Zhao SN,
   7. et al.

   (2015) Study on the effect of urinary kallidinogenase after thrombolytic treatment for acute cerebral infarction. Eur Rev Med Pharmacol Sci 19, 1009–1012.
10. ↵
    1. Sharma JN,
    2. Narayanan P

    (2014) The kallikrein-kinin pathways in hypertension and diabetes. Prog Drug Res 69, 15–36.
11. ↵
    1. Zhao Z,
    2. Bai Q,
    3. Sui H,
    4. Xie X,
    5. Wen F

    (2009) Fast multimode MRI based emergency assessment of hyperacute stroke thrombolysis. Neurol Res 31, 346–350.
12. ↵
    1. Kanazawa M,
    2. Igarashi H,
    3. Kawamura K,
    4. Takahashi T,
    5. Kakita A,
    6. Takahashi H,
    7. et al.

    (2011) Inhibition of VEGF signaling pathway attenuates hemorrhage after tPA treatment. J Cereb Blood Flow Metab 31, 1461–1474.